Post-approval studies (Phase 4)Study completedNCT05207865
What this trial is testing
Safety and Tolerability Study of Daily Dosing Rimegepant in Episodic Migraine Prevention
Who this might be right for
MigraineEpisodic MigrainePhonophobia+1 more
Pfizer 441